covid 19 News and Research

RSS

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

Researchers investigated COVID-19-triggered changes in the levels of cyclins and cyclin-dependent kinases inside host cells.

10 May 2022

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Investigators illustrated that a SARS-CoV-2 Omicron infection post-booster vaccination imparts robust, long-lasting immunity against future re-infections.

10 May 2022

Elevated and sustained autoantibodies following COVID-19

A new study demonstrated that autoantibody levels rise following acute SARS-CoV-2 infection and remain to be elevated for about six months.

10 May 2022

Travel nurses see swift change of fortunes as covid money runs dry

Jones, who has been a nurse for 17 years, caught up with a Facebook group for travel nurses and saw she wasn't alone. Nurses had reported abruptly losing jobs and seeing their rates slashed as much as 50% midcontract.

10 May 2022

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

In this study, the authors have specifically studied the interactions of epithelial cells, a subset of cytokines and macrophages.

10 May 2022

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

A new study has focused on the microcirculatory factors associated with neurological complications of COVID-19.

10 May 2022

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

A new paper published in Signal Transduction and Targeted Therapy reports the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2.

10 May 2022

Systematic review with meta-analysis of the current evidence regarding the incidence of long COVID symptomatology

The researchers searched several databases looking for observational studies on the incidence of long COVID symptoms and signs by organ system, based on the World Health Organization (WHO) criteria.

10 May 2022

The potential for SARS-CoV-2 to be transmitted biologically or mechanically by arthropods

Researchers examined results from field studies, laboratory-based research, and environmental studies to analyze the potential of SARS-CoV-2 transmission either biologically or mechanically among arthropods.

10 May 2022

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

A new study published in the journal Nature aimed to determine the extent to which Omicron infection elicits protection against other SARS-CoV-2 variants in both vaccinated and unvaccinated individuals.

10 May 2022

CDC/FDA reports on VAERS - no association between vaccines and increased mortality

A U.S. population-wide study published in medRxiv* preprint server provides information and context about deaths reported to VAERS following COVID-19 vaccination.

10 May 2022

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

A study recently published in the journal Cell Host & Microbe has described that all three sublineages of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit similar host cell entry efficiency and are neutralized equally by antibodies generated in response to coronavirus disease 2019 (COVID-19) booster vaccination

10 May 2022

About 15 million additional deaths attributed to COVID-19 between January 2020 and December 2021

The World Health Organization (WHO) has released new figures showing that the coronavirus disease 2019 (COVID-19) pandemic caused almost 15 million deaths directly or indirectly. These deaths comprise the excess mortality over the two years 2020 and 2021, attributable to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

9 May 2022

Remdesivir shows no significant effect on patients with COVID-19 in Solidarity trial

A recent study published in the journal The Lancet summarized the final results of the Solidarity trial which aimed at finding out which drugs were most effective at reducing the severity of the disease among hospitalized patients.

9 May 2022

More evidence that pediatric COVID vaccination prevents MIS-C

Researchers designed a nationwide pediatric COVID-19 research project based on real-time data since the early phase of the pandemic.

9 May 2022

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Scientists have focused on determining the cause-effect relationship between SARS-CoV-2 antibody titers and COVID-19 disease severity.

9 May 2022

Telemedicine boom reduced racial gaps in primary care appointment completion rates

Historically, there has been racial inequity when it comes to primary care appointments, which are vital for managing and preventing chronic disease.

9 May 2022

Research finds an increase in loneliness associated with COVID-19 pandemic

People around the world experienced an increase in loneliness during the COVID-19 pandemic, which, although small, could have implications for people's long-term mental and physical health, longevity, and well-being, according to research published by the American Psychological Association.

9 May 2022

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Annual cancer deaths in sub-Saharan Africa (SSA) could reach 1 million by 2030, nearly double the 520,000 deaths from cancer that occurred in 2020.

9 May 2022

Q&A: COVID-19 pandemic has widened gender inequities in health

Health inequalities facing women and girls, already stark before the onset of COVID-19, have widened glaringly during the pandemic. Lockdowns restricted access to sexual and reproductive health services, increased violence against women, and interrupted girls’ education.

9 May 2022

covid 19 News and Research

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Elevated and sustained autoantibodies following COVID-19

Travel nurses see swift change of fortunes as covid money runs dry

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

Systematic review with meta-analysis of the current evidence regarding the incidence of long COVID symptomatology

The potential for SARS-CoV-2 to be transmitted biologically or mechanically by arthropods

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

CDC/FDA reports on VAERS - no association between vaccines and increased mortality

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

About 15 million additional deaths attributed to COVID-19 between January 2020 and December 2021

Remdesivir shows no significant effect on patients with COVID-19 in Solidarity trial

More evidence that pediatric COVID vaccination prevents MIS-C

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Telemedicine boom reduced racial gaps in primary care appointment completion rates

Research finds an increase in loneliness associated with COVID-19 pandemic

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Q&A: COVID-19 pandemic has widened gender inequities in health

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News